Literature DB >> 16291031

Physiology of penile erection and pathophysiology of erectile dysfunction.

Robert C Dean1, Tom F Lue.   

Abstract

This article reviews the physiology of penile erection, the components of erectile function, and the pathophysiology of erectile dysfunction. The molecular and clinical under-standing of erectile function continues to gain ground at a particularly fast rate. Advances in gene discovery have aided greatly in working knowledge of smooth muscle relaxation/contraction pathways. The understanding of the nitric oxide pathway has aided not only in the molecular understanding of the tumescence but also greatly in the therapy of erectile dysfunction.

Entities:  

Mesh:

Year:  2005        PMID: 16291031      PMCID: PMC1351051          DOI: 10.1016/j.ucl.2005.08.007

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  120 in total

1.  Vascular hypertrophy and remodeling in secondary hypertension.

Authors:  D Rizzoni; E Porteri; M Castellano; G Bettoni; M L Muiesan; P Muiesan; S M Giulini; E Agabiti-Rosei
Journal:  Hypertension       Date:  1996-11       Impact factor: 10.190

2.  Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle.

Authors:  K M Azadzoi; I Saenz de Tejada
Journal:  J Urol       Date:  1991-07       Impact factor: 7.450

3.  Aging and sexual function in men.

Authors:  D L Rowland; W J Greenleaf; L J Dorfman; J M Davidson
Journal:  Arch Sex Behav       Date:  1993-12

4.  Impotence following radical prostatectomy: insight into etiology and prevention.

Authors:  P C Walsh; P J Donker
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

Review 5.  A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction.

Authors:  Selim Cellek; Rowland W Rees; Jas Kalsi
Journal:  Expert Opin Investig Drugs       Date:  2002-11       Impact factor: 6.206

6.  Venogenic impotence following dermal graft repair for Peyronie's disease.

Authors:  B L Dalkin; M F Carter
Journal:  J Urol       Date:  1991-09       Impact factor: 7.450

7.  Nitric oxide synthase: a new diagnostic tool for neurogenic impotence.

Authors:  G Brock; L Nunes; H Padma-Nathan; S Boyd; T F Lue
Journal:  Urology       Date:  1993-10       Impact factor: 2.649

8.  Electrophysiological study of relations between the dorsal nerve of the penis and the lumbar sympathetic chain in the rat.

Authors:  F Giuliano; O Rampin; A Jardin; J P Rousseau
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

9.  Single potential analysis of cavernous electrical activity in impotent patients: a possible diagnostic method for autonomic cavernous dysfunction and cavernous smooth muscle degeneration.

Authors:  C G Stief; M Djamilian; P Anton; W de Riese; E P Allhoff; U Jonas
Journal:  J Urol       Date:  1991-09       Impact factor: 7.450

10.  Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men.

Authors:  R Virag; P Bouilly; D Frydman
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

View more
  107 in total

1.  Nitric oxide-induced vasorelaxation in response to PnTx2-6 toxin from Phoneutria nigriventer spider in rat cavernosal tissue.

Authors:  Kenia P Nunes; Marta N Cordeiro; Michael Richardson; Marcia N Borges; Simone O F Diniz; Valbert N Cardoso; Rita Tostes; Maria Elena De Lima; Robert Clinton Webb; Romulo Leite
Journal:  J Sex Med       Date:  2010-08-16       Impact factor: 3.802

2.  Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.

Authors:  J Taylor Whaley; Lawrence B Levy; David A Swanson; Thomas J Pugh; Rajat J Kudchadker; Teresa L Bruno; Steven J Frank
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-31       Impact factor: 7.038

Review 3.  Prostatic irradiation-induced sexual dysfunction: a review and multidisciplinary guide to management in the radical radiotherapy era (Part I defining the organ at risk for sexual toxicities).

Authors:  Marigdalia K Ramirez-Fort; Marc J Rogers; Roberto Santiago; Sean S Mahase; Melissa Mendez; Yi Zheng; Xiang Kong; James A Kashanian; M Junaid Niaz; Shearwood McClelland; Xiaodong Wu; Neil H Bander; Peter Schlegel; John P Mulhall; Christopher S Lange
Journal:  Rep Pract Oncol Radiother       Date:  2020-03-19

4.  Network position and sexual dysfunction: implications of partner betweenness for men.

Authors:  Benjamin Cornwell; Edward O Laumann
Journal:  AJS       Date:  2011-07

Review 5.  Cavernous smooth muscles: innovative potential therapies are promising for an unrevealed clinical diagnosis.

Authors:  Ahmed Mohamed Hassanin; Ahmed Zain Abdel-Hamid
Journal:  Int Urol Nephrol       Date:  2019-10-15       Impact factor: 2.370

6.  Serum Arginase II level can be a novel indicator for erectile dysfunction in patients with vasculogenic erectile dysfunction: a comparative study.

Authors:  Abdel Shakour Abdel Hafez Abdel Wahed; Mohamed Abdel Mawgood Amer; Nagah Mohamed Abou Mohamed; Mohamed Ismael Mobasher; Hassan Mamdouh; Sameh Fayek GamalEl Din; Mohammed Said ElSheemy
Journal:  Int Urol Nephrol       Date:  2018-06-28       Impact factor: 2.370

Review 7.  Arginase: an old enzyme with new tricks.

Authors:  Ruth B Caldwell; Haroldo A Toque; S Priya Narayanan; R William Caldwell
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

Review 8.  Normal male sexual function: emphasis on orgasm and ejaculation.

Authors:  Amjad Alwaal; Benjamin N Breyer; Tom F Lue
Journal:  Fertil Steril       Date:  2015-09-16       Impact factor: 7.329

9.  Predictors of Erectile Function Normalization in Men With Erectile Dysfunction Treated With Placebo.

Authors:  John P Mulhall; Martin Carlsson; Vera Stecher; Li-Jung Tseng
Journal:  J Sex Med       Date:  2018-05-09       Impact factor: 3.802

10.  RE: Evaluation of sexual function in patients submitted to ureteroscopic procedures.

Authors:  Mustafa Kadihasanoglu; Emin Özbek
Journal:  Int Braz J Urol       Date:  2016 Jul-Aug       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.